Conventional dendritic cells (cDCs) are versatile activators of immune responses that develop as part of the myeloid lineage downstream of hematopoietic stem cells. We have recently shown that in mice precursors of cDCs, but not of other leukocytes, are marked by expression of DNGR-1/CLEC9A. To genetically deplete DNGR-1-expressing cDC precursors and their progeny, we crossed Clec9a-Cre mice to Rosa-lox-STOP-loxdiphtheria toxin (DTA) mice. These mice develop signs of age-dependent myeloproliferative disease, as has been observed in other DC-deficient mouse models. However, despite efficient depletion of cDC progenitors in these mice, cells with phenotypic characteristics of cDCs populate the spleen. These cells are functionally and transcriptionally similar to cDCs in wild type control mice but show somatic rearrangements of Ig-heavy chain genes, characteristic of lymphoid origin cells. Our studies reveal a previously unappreciated developmental heterogeneity of cDCs and suggest that the lymphoid lineage can generate cells with features of cDCs when myeloid cDC progenitors are impaired.
Conventional dendritic cells (cDCs) are versatile activators of immune responses that develop as part of the myeloid lineage downstream of hematopoietic stem cells. We have recently shown that in mice precursors of cDCs, but not of other leukocytes, are marked by expression of DNGR-1/CLEC9A. To genetically deplete DNGR-1-expressing cDC precursors and their progeny, we crossed Clec9a-Cre mice to Rosa-lox-STOP-loxdiphtheria toxin (DTA) mice. These mice develop signs of age-dependent myeloproliferative disease, as has been observed in other DC-deficient mouse models. However, despite efficient depletion of cDC progenitors in these mice, cells with phenotypic characteristics of cDCs populate the spleen. These cells are functionally and transcriptionally similar to cDCs in wild type control mice but show somatic rearrangements of Ig-heavy chain genes, characteristic of lymphoid origin cells. Our studies reveal a previously unappreciated developmental heterogeneity of cDCs and suggest that the lymphoid lineage can generate cells with features of cDCs when myeloid cDC progenitors are impaired.
Keywords: dendritic cell, development, clec9a/Dngr-1, Dc depletion, myelopoiesis, lymphopoiesis, fate mapping inTrODUcTiOn Conventional dendritic cells (cDCs) are remarkable activators of adaptive immune responses with a superior capacity to capture, process, and present antigens to T cells (1-4). Through the production of cytokines, cDCs further direct effector responses and play essential roles in immune homeostasis and innate immunity (5) (6) (7) (8) (9) (10) . This versatility of cDCs in immune responses is regulated in part through the functional specialization of cDC subpopulations. cDCs exist as two main developmentally distinct subsets that are found across lymphoid and non-lymphoid organs. cDC1 requires the transcription factors Batf3, IRF8, and ID2 for their development and are marked by expression of XCR1 and DNGR-1 (a.k.a. CLEC9A) across tissues and species (1, 11, 12) . They are exceptional activators of CD8 T cells owing to their superior capacity to take up dead cells and cross-present antigens (1-4). Through the production of IL-12, cDC1 promotes type-I immune responses hallmarked by expression of Th1 cytokines (1, 5) . In contrast, the differentiation and function of the cDC2 subset is controlled by the transcription factors IRF4, KLF4, RelB, and ZEB2 (1, [11] [12] [13] [14] , although ZEB2 may predominantly control cDC2 differentiation in inflammatory conditions (15) . Phenotypically cDC2 can be distinguished from cDC1 by expression of CD11b, CD172a, and CLEC4A4 (DCIR2), as well as expression of IRF4 and concomitant lack of IRF8 (1, 11, 12, 16 ). cDC2 appears to play a more prominent role in CD4 T-cell activation and the promotion of Th2 and Th17 responses, particularly at mucosal surfaces (17, 18) .
Although the existence of cDCs as independent cell type has been a matter of intense debate, lineage tracing and other studies in mice have established that cDCs develop as distinct hematopoietic cell lineage (12, 19, 20) . Single-cell analyses have recently suggested that myeloid lineage decisions take place early in hematopoiesis but the production of lymphoid and myeloid lineages is thought to branch after the lymphoid-primed multipotent progenitor (LMPP) stage (20) (21) (22) (23) (24) . Downstream of LMPP, in a stepwise differentiation process, common myeloid progenitors give rise to a lineage (lin) negative CD115 + CD117 hi CD135
+ fraction of bone marrow that generates monocytes, plasmacytoid DCs (pDCs), and cDCs and has therefore been termed macrophage and DC progenitor (MDP) (25, 26) . Whether MDPs are a true bi-potent developmental intermediate for cDCs/pDCs and monocytes is controversial (27) . MDPs further give rise to common monocyte progenitors that exclusively generate monocytes (28) and a lin − CD115 + CD117 low CD135 + fraction of cells termed common DC progenitors (CDP) that lose monocyte potential but generate cDCs and pDCs (29, 30) . Within CDPs the expression of the C-type lectin receptor DNGR-1 (encoded by the Clec9a gene) distinguishes cells with exclusive cDC potential (19) . CDPs further differentiate into pre-cDCs, which also express DNGR-1 (19) and travel via blood to peripheral organs, where their terminal differentiation into cDC1 and cDC2 takes place in response to environmental cues (31) (32) (33) . Some pre-cDCs exist as pre-committed subsets that can be already distinguished in bone marrow based on the expression of specific surface markers and transcription factors (32, 34, 35) . The developmental steps of cDC differentiation appear conserved, as equivalent progenitors and transcriptional requirements for cDC differentiation have been identified in humans (12, (36) (37) (38) (39) (40) .
By crossing mice expressing Cre recombinase (Cre) under the control of the endogenous Clec9a promoter to Rosa26-lox-STOP-lox-yellow fluorescent protein (YFP) reporter mice, we were able to demonstrate that Clec9a expression history faithfully traces the cDC lineage, including the main cDC1 and cDC2 subsets, but no other myeloid and lymphoid lineages in steady state as well as during inflammation (19) . In this model, any cell-expressing Cre becomes irreversibly labeled with YFP, thereby allowing us to trace DNGR-1-expressing CDP and precDC irrespective of continuous DNGR-1 expression (19) . One exception to faithful tracing of the cDC lineage is pDCs, which do not arise from DNGR-1-expressing cDC progenitors but express low levels of DNGR-1 in their differentiated form (19) . In pDCs Clec9a expression history, therefore, is not necessarily a measure of cell origin (19) . The same applies to cDC1, which express high levels of DNGR-1 and could become labeled with YFP because they express Cre in their differentiated form (19) . However, cDC1 are CDP-derived (1, 11) and arise from DNGR-1-expressing cDC progenitors upon adoptive transfer, confirming their classification as cDCs (19) . Despite these limitations, Clec9a-Cre mice offer a powerful means to identify cDCs as descendants from Clec9a-expressing cDC progenitors and to trace the cDC lineage, particularly the cDC2 subtype, which lacks DNGR-1 in its differentiated form.
Although we have reached a consensus that cDCs arise as part of the myeloid lineage, several studies have suggested a lymphoid path to cDC development. Purified lymphoid progenitors can differentiate into cells resembling cDC1 and cDC2 after adoptive transfer and in vitro (41) (42) (43) (44) (45) (46) (47) . This process appears to be driven by the same lineage promoting transcription factors that control cDC development from myeloid progenitors, such as IRF8 (46, 48) . Additionally, B-cell receptor gene rearrangements at the IgH locus, indicative of a lymphoid past, can be found in populations of thymic cDCs, some splenic cDC1, and pDCs (49) (50) (51) (52) . Nevertheless, fate-mapping studies in steady-state mice have excluded a prominent contribution of lymphoid progenitors to the steady-state cDC pool (53, 54) and have confirmed a binary branching of lymphoid and myeloid lineages downstream of hematopoietic stem cells (21) . However, whether lymphoid progenitors can serve as an alternative path to DC poiesis in conditions of inflammation or when myeloid cDC progenitors are absent has not been investigated. Because cDCs generated in vitro from purified human lymphoid or myeloid progenitors are indistinguishable by gene expression analysis (42) , addressing this question requires faithful ontogeny-based fate-mapping models.
Here, we investigated cDC development in mice in conditions in which cDC progenitors are impaired. We crossed Clec9a-Cre mice to Rosa26-lox-STOP-lox-diphtheria toxin (DTA) reporter mice (55) 
Rosa
DTA mice lack cDC progenitors and cDC1 but not cDC2. We show that in the absence of cDC progenitors, cells with features of cDC2 arise via an alternative developmental path. These cells show similarities to bona fide cDC2 in terms of transcriptional profile and inflammatory cytokine production but exhibit evidence of Ig receptor rearrangements, indicating a lymphoid origin. Thus, our data suggest a previously unrecognized role for lymphoid progenitors as an alternative source of cDC2, when the conventional myeloid path of cDC development is blocked.
MaTerials anD MeThODs

Mice
Clec9a-Cre (19), Rosa26-lox-STOP-lox-EYFP (56), Rosa26-lox-STOP-lox-DTA (55), Rosa26-lox-STOP-lox-DTR (57), C57BL/6J, and B6.SJL mice were bred at Cancer Research UK, at ENVIGO or the Biomedical Center in specific pathogen-free conditions. All animal experiments were performed in accordance with national and institutional guidelines for animal care and approved by the Francis Crick Institute Animal Ethics Committee, the UK Home Office, or the Regierung of Oberbayern.
cell isolation
Spleen and lymph nodes were cut into small pieces and digested with Collagenase IV (200 U/mL; Worthington) and DNase I (0.2 mg/mL Roche) in RPMI for 30 min at 37°C. Cells were A Lymphoid Path to cDCs cell culture
CD11c
+ cells from spleen were enriched by positive selection using magnetic beads and LS-columns (Miltenyi), cultured in complete RPMI (10% FCS, penicillin/streptomycin, nonessential amino acids, sodium pyruvate, L-glutamine, 0.025-mM β-mercaptoethanol), and stimulated with LPS (100 ng/mL) or CpG (0.5 µg/mL) for 2 h before addition of brefeldin A (5 µg/ mL) for an additional 4 h. 
Flow cytometry
Data were collected on a LSR Fortessa (BD Biosciences) and analyzed with FlowJo software (Tree Star, Inc.). Cell sorting was performed on an Aria III Fusion (BD Biosciences). Antibodies used in this study can be found in Table S2 in Supplementary Material. For intracellular cytokine staining cells were fixed with 2% paraformaldehyde (15 min, room temperature), then washed in FACS buffer with 0.05% saponin and stained in 0.5% saponin. IRF8 and IRF4 were stained in Foxp3 transcription factor staining set (eBioscience-00-5523-00) and Zbtb46 in transcription factor buffer from BDBioscience-562574. Dead cells were identified with Dapi or live/dead fixable violet (Invitrogen) or zombie UV dye (Biolegend).
Microarray analysis
CD11c
+ cells were enriched using magnetic beads and LS columns (Miltenyi Biotec). Cells were then sorted as CD11c
Rosa DTA mice or as YFP
Total RNA was isolated using Qiagen RNeasy Micro Kit and prepared for hybridization on Affymetrix Mouse Gene 1.0 ST Arrays. We processed microarray data with R/bioconductor (R version 3.4.2) using the annotation package "mogene10sttranscriptcluster.db" version 8.7.0. The Robust Multichip Average (RMA) algorithm was used to extract raw expression values (library "oligo, " version 1.42.0 and "pd. mogene.1.0.st.v1" version 3.14.1). We subsequently removed probe sets with zero variance and kept the ones with a median log2 expression level higher than 4.5 in at least one condition. Many-to-one probe-sets-to-gene relationships were resolved by retaining per gene only the probe set with the highest interquartile range of expression levels across the samples. External data were merged and batch corrected using ComBat (library "sva, " version 3.26.0). Principle component analysis (PCA) was performed on 50% of the genes defined by highest variance across all samples. Heatmaps were generated using function pheatmap (library pheatmap, version 1.0.8) including gene-based scaling and clustering.
DJ-rearrangement Polymerase chain reaction (Pcr)
Genomic DNA was extracted by phenol chloroform extraction and 20-ng DNA were used per reaction. PCR for the IgH locus (Dfl16 and Dsp2 D gene families) (58) 
Diphtheria Toxin (DT)-Mediated cell ablation
Mice were injected intraperitoneally with 25 ng per gram body weight DT (SIGMA). Spleens were analyzed 24 h later.
statistical analysis
Statistical testing was performed using two-sided, unpaired Welch t-tests in GraphPad Prism 6 software (GraphPad, La Jolla, CA, USA). A p < 0.05 was considered significant.
resUlTs
Clec9a
Cre/Cre Rosa DTA 
Mice Develop Myeloproliferative Disease
To generate mice lacking progeny derived from cDC-restricted progenitors, we crossed Clec9a-Cre mice to Rosa26-lox-STOPlox-DTA reporter mice to induce apoptotic cell death in Creexpressing cells and their progeny (55) . We have previously shown that the penetrance of Cre-mediated recombination is increased in homozygous Clec9a-Cre mice without affecting specificity (19) . For most experiments, we therefore generated mice homozygous for the Clec9a-Cre locus that were either heterozygous or homozygous for the Rosa26-lox-STOP-lox-DTA allele (henceforth referred to as Clec9a
Cre mice, henceforth referred to as controls, Figure 1A ). Despite prominent splenomegaly in mice 10 weeks or older, no difference in bone-marrow cellularity was observed ( Figure 1A) . Rosa DTA mice at 6 and 14-17 weeks of age and the concentrations of FLT3L were determined by ELISA. Each symbol represents one mouse. ns, not significant; * p < 0.05, ** p < 0.001, and *** p < 0.0001. DC deficiency is associated with myeloproliferation leading to systemic neutrophilia and monocytosis (59) (60) (61) (62) . In 5-weekold mice, we observed no differences in the frequency and number of Ly-6C + CD11b + myeloid cells but in mice 10 weeks or older Ly-6C + CD11b + cells were significantly increased (Figures 1B,C) . This age-dependent increase in Ly-6C + CD11b + cells encompassed both neutrophils and monocytes, whereas red pulp macrophages were not affected (Figures S1A-C in Supplementary Material). Myeloproliferation in DC-deficient mice is thought to be secondary to dysregulation of growth factors, such as FLT3L, G-CSF, or GM-CSF (59, 61) . Clec9a
Cre/Cre Rosa DTA mice displayed increased serum levels of FLT3L, with a slight increase evident even before the onset of overt splenomegaly in 6-week-old mice ( Figure 1D ). Systemic levels of other cytokines implicated in neutrophil and monocyte homeostasis were unaffected ( Figure S1D respectively (Figure 2A ) (12) . At 10 weeks of age Clec9a
Cre/Cre Rosa DTA mice showed a twofold reduction in the frequency of splenic cDCs compared to controls. Due to the increased organ cellularity, however, there was no effect on the absolute number of splenic CD11c (Figures 2A,B) . The same was observed in older Clec9a
Cre/Cre Rosa DTA mice (14-17 weeks; Figure 2B ). In 5-week-old mice that do not exhibit increased spleen cellularity, a reduction of splenic CD11c +
MHCII
+ cells was apparent in cell counts (Figure 2B ), yet cell depletion was surprisingly inefficient (about 3.5-fold). When we further separated CD11c + MHCII + cells into cDC1 and cDC2 using the surface markers CD24 and CD11b (Figure 2A) , we found that cDC1 were completely depleted in spleens from Clec9a
Cre/Cre Rosa DTA mice at all ages examined ( Figure 2C and unpublished observations) . In contrast, CD11b + cDC2 showed a significant but small reduction ( Figure 2C ) only in 5-week-old Clec9a
Cre/Cre Rosa DTA mice and their frequency and absolute number was not reduced in mice 10 weeks or older ( Figure 2C ). This could be seen in other lymphoid organs, as well as in mice heterozygous for Cre expression, as the lymph nodes of Clec9a
Rosa DTA mice also lacked cDC1 but not resident cDC2 or migratory CD103
+
CD11b
+ and CD103 -CD11b + cDC2 ( Figure  S2F in Supplementary Material). Finally, these findings could be extended to non-lymphoid organs as cDC1 but not CD103 (Figures 3A,B) and this was true when pre-cDC were also identified irrespective of the CD135 marker as the lin 
CD135
− cells were found in the splenic pre-cDC gate, those cells expressed reduced levels of CD11c, indicating that they were contaminants rather than bona fide pre-cDCs (Figures 3D-F; Figures S3B,C in Supplementary Material). A more efficient depletion of pre-cDCs compared with CDPs is to be expected because Cre-mediated DNA rearrangement in pre-cDCs is higher than in CDPs, reflecting the developmental hierarchy of DNGR-1 expression in rapidly cycling progenitors (19 Rosa DTA mice than from control mice produced TNF, whereas this was not the case for IL-12 ( Figure 4B) . Reduced TNF production after LPS stimulation was already present in cDC2 from young Clec9a
Cre/Cre Rosa DTA mice that did not yet display myeloproliferation (Figure 4C) indicating that it was not merely a functional adaptation to the myeloproliferative environment. We conclude that cDC2 from Clec9a
Cre/Cre Rosa DTA mice are broadly similar to cDC2 from control mice, other than a slight impairment in the production of TNF after LPS stimulation. Figure 5 ; Figure S3 and Table S1 in Supplementary Material). We chose this experimental strategy to ensure comparison to bona fide cDC2 arising from Clec9a-expressing myeloid cDC progenitors. Our analysis revealed surprisingly few differences in gene expression, indicating that cDC2 from Clec9a
Cre/Cre Rosa DTA mice are very similar to YFP + cDC2. Interestingly, among the 50 most significantly differentially expressed genes, only 11 showed more than a twofold difference and we found CD135 as a top hit (Table S1 in Supplementary Material). The expression of CD135 was about twofold lower in cDC2 from Clec9a
Cre/Cre Rosa DTA mice than in YFP + cDC2 (Table  S1 in Supplementary Material), raising the possibility that expression of the lineage defining marker CD135 may be dysregulated at the mRNA level. Consistent with that notion, staining for CD135 was reduced on cDC2 from Clec9a
Cre/Cre Rosa DTA mice ( Figure 4A ). However, incubation of cDCs with FLT3L inhibited CD135 staining intensity, even in conditions in which endocytosis should be blocked ( Figure S3D in Supplementary Material), suggesting that, when occupied by FLT3L, CD135 may no longer be freely available for antibody binding. Therefore, decreased CD135 staining on cDC2 from Clec9a
Cre/Cre Rosa DTA mice may reflect the fact that the receptor is engaged by FLT3L, as well as a possible reduction in gene expression. We next used cDC and macrophage core gene signatures (65) Rosa DTA mice and YFP + cDC2 showed greater similarity to splenic cDC2 than to cDC1 or red pulp macrophages (Figures 5A,B ; Figure S3 in Supplementary Material). cDC2 from Clec9a
Cre/Cre Rosa DTA mice did not display a migratory cDC signature ( Figure S4 in Supplementary Material), suggesting that they are not cDC2 that have aberrantly migrated from the periphery.
We next performed principal component analysis (PCA) in the context of published datasets for splenic cDCs, thymic cDCs, migratory cDCs, splenic pDCs, macrophages, and monocytes.
Notably, cDC2 from Clec9a
Cre/Cre Rosa DTA mice were most closely related to YFP + cDC2 and splenic cDC2 and clustered far away from monocytes/macrophages, thymic cDCs, or pDCs ( Figure 5C ). In humans, a subset of cDC2 has been identified that appears to be related to pDCs (66) . These cells can be distinguished from cDC2 and pDCs by expression of signature genes, including Axl, Pp1rb, Dab2, CD22, and IL3Ra (66) . However, we found no enrichment of the Axl gene signature in cDC2 from Clec9a
Cre/Cre Rosa DTA mice compared with YFP + cDC2 ( Figure 5D ). Taken together, these data demonstrate that cDC2 from Clec9a
Cre/Cre Rosa DTA mice do not show a comprehensive loss of cDC identity and resemble cDC2 from wild type mice.
CLPs can give rise to cDCs in vivo and in vitro under certain conditions (41) (42) (43) (44) (45) (46) (47) (48) and pDCs in normal mice can originate from myeloid or lymphoid progenitors that appear phenotypically indistinguishable except for a history of RAG expression in those originating from the latter (50, (67) (68) (69) . We therefore sorted CD11b 
Rosa
DTA mice also showed clear evidence of Ig gene rearrangements, which were completely absent in cDC2 from control mice (Figures 5E,F ; Figure S5C in Supplementary Material). In summary, cDC2 that arise in the absence of Clec9a-expressing cDC progenitors are transcriptionally similar to bona fide cDC2 but they exhibit RAG gene expression history in the form of D-J somatic rearrangements, indicating a putative lymphoid origin.
DiscUssiOn
Although the existence of a lymphoid path to cDC development in mice has been suggested (43, 47, 49, 50, 70) , in steady-state cDCs arise primarily from myeloid progenitors (53) . Here, we report the generation of Clec9a
Cre/Cre Rosa DTA mice as a model to constitutively deplete Clec9a-expressing cDC progenitors and their progeny. We show that in the absence of these myeloid-derived cDC progenitors, cells that are phenotypically and transcriptionally similar to bona fide cDC2 develop in spleen. These cells show RAG gene expression history in the form of D-J rearrangements at the IgH locus indicating a relation to the lymphoid branch of hematopoiesis. Therefore, our study suggests that lymphopoiesis can contribute to the generation of cDC-like cells in a situation in which myeloid cDC progenitors are impaired. This observation opens an interesting conundrum, namely, whether such cells Rosa DTA mice is shown. It was normalized to MFI on the same population from control mice, which is set as 1 (n = 4). Each symbol represents one mouse. ns, not significant; * p < 0.05, ** p < 0.001, and *** p < 0.0001.
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should be considered part of the cDC lineage. We and others have proposed that mononuclear phagocytes should predominantly be defined on the basis of their ontogeny (12, 71, 72) . However, environmental imprinting appears to be a major identity determining criterion for mononuclear phagocytes (73) (74) (75) (76) (77) . Therefore, an ontogenetic view to cell definition may be less tenable if cell Rosa DTA mice of the indicated ages were enriched using magnetic beads, stimulated with lipopolysaccharide (LPS) (100 ng/mL) or CpG (0.5 µg/mL) for 6 h followed by intracellular cytokine staining. CD11c populations with different origins turn out to be identical by all measures examined. Because cDC2 in Clec9a
Cre/Cre Rosa DTA mice are not CDP-derived but show lymphoid gene expression history, we suggest to refer to these cells as lymphoid DC2 for the time being (12) . Although we find strong similarities between cDC2 and lymphoid DC2, additional studies are necessary to further define the transcriptional and growth factor requirements, as well as functional properties of lymphoid DC2 to firmly establish their lineage affiliation and determine whether these cells should be considered a new type of mononuclear phagocyte (12) .
As cDC differentiation from precursors is thought to be homeostatically regulated by the size of the mature cDC pool (78, 79) , we cannot formally exclude at this point that some CDPs escape deletion in Clec9a
Cre/Cre Rosa DTA mice to preferentially expand and contribute to the cDC2 population. However, our data demonstrate that at least part of the cDC2 pool in Clec9a
Cre/Cre Rosa DTA mice derives from a cell type that has undergone Ig gene rearrangement and that pool is therefore qualitatively distinct from CDP-derived cDC2. Whether these ontogenetically distinct cDC2s arise from early lymphoid-committed progenitors, such as CLPs, is an attractive possibility that will need to be explored. However, it is worth mentioning that some myeloid progenitors reportedly express RAG1 and can generate pDCs with D-J rearrangements in vitro (50) . Such RAG1-expressing myeloid progenitors, which would presumably lack DNGR-1, could contribute to cDC2 generation in Clec9a
Cre/Cre Rosa DTA mice, in which case our designation of these cells as "lymphoid cDC2" would be incorrect. Finally, it is possible that pDCs, some of which have a lymphoid past (49, 50) , could convert to lymphoid cDC2 in the FLT3L-rich environment of Clec9a
Cre/Cre Rosa DTA mice, although this is difficult to reconcile with the fact that we failed to find any pDC-specific transcripts in lymphoid DC2 ( Figure 5 and unpublished observations). Another intriguing observation is that lymphoid DC2 display decreased surface staining for CD135. Gene expression analysis suggests that CD135 may be dysregulated at the RNA level ( Figure 5) . However, it is equally possible that CD135 could be downregulated upon continuous receptor engagement by FLT3L (80) for antibody binding ( Figure S3D in Supplementary Material).
As FLT3L-deficient mice lack all cDCs (33, 81) , it is unlikely that lymphoid DC2 arise independently of FLT3L. It will be important to determine whether different growth factors may preferentially promote the differentiation of lymphoid and myeloid progenitors into cDCs. The fact that lymphoid DC2 are strikingly similar to bona fide cDC2 of myeloid origin in terms of transcriptional profile is in agreement with data demonstrating that in vitro generated human myeloid-derived cDC1 are indistinguishable from ones derived from human lymphoid-committed progenitors (42) . These data suggest a primary role for the environment in the functional imprinting of cDCs, similar to observations made for macrophages and monocytes (73) (74) (75) (76) . Despite functional similarities between lymphoid DC2 and cDC2 in vitro, these cells respond somewhat differently to the TLR ligand LPS. These data raise the possibility that lymphoid DC2 are not fully functionally equivalent to cDC2, which needs to be addressed experimentally in more detail. In this context, it is noteworthy that Clec9a
Cre/Cre Rosa DTA mice develop signs of systemic myeloproliferation, which is typical of mice lacking both cDC1 and cDC2 but has not been reported in mice lacking only the cDC1 subset (82, 83) .
It will be important to determine whether additional situations exist where a lymphoid path may contribute to generating or replacing bona fide cDC2, either to ensure functional redundancy or to mediate specific immune functions. Notably, RAG-expressing immune-restricted progenitors contribute to embryonic myelopoiesis in the fetal liver and, although this occurs before the onset of definitive hematopoiesis (84) , it indicates that lymphoid and myeloid lineage decisions are not always binary. During emergency hematopoiesis distinct monocyte progenitors have been suggested to respond to inflammatory stimuli on a per need basis, yielding a situation-adapted repertoire of inflammatory monocytes (85) . It is intriguing to speculate that, in a similar manner, lymphoid and myeloid progenitors may be differentially triggered in certain conditions of inflammation to generate lymphoid DC2 and cDC2, respectively.
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